The International Diagnostic Nuclear Medicines market size was xxx million USD with a CAGR xx % from 2015- 2019. It will stretch to xxx million USD in 2020 with a CAGR of xx % from 2020 to 2025.
Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
As the report focuses on global Diagnostic Nuclear Medicines market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
In market segmentation by manufacturers, the report covers the following companies-
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
In market segmentation by geographical regions, the report has analyzed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In market segmentation by types covers:
Tc-99m
F-18
Other
In market segmentation by applications :
Oncology
Cardiology
Other
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Diagnostic Nuclear Medicines market for the forecast period 2020 - 2025?
• What are the driving forces in the Diagnostic Nuclear Medicines market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Diagnostic Nuclear Medicines industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?